PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SLNO vs. TRML
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SLNO and TRML is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SLNO vs. TRML - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Soleno Therapeutics, Inc. (SLNO) and Tourmaline Bio Inc. (TRML). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%JulyAugustSeptemberOctoberNovemberDecember
171.35%
-71.39%
SLNO
TRML

Key characteristics

Sharpe Ratio

SLNO:

0.45

TRML:

0.10

Sortino Ratio

SLNO:

1.06

TRML:

0.74

Omega Ratio

SLNO:

1.12

TRML:

1.10

Calmar Ratio

SLNO:

0.27

TRML:

0.10

Martin Ratio

SLNO:

1.91

TRML:

0.17

Ulcer Index

SLNO:

13.36%

TRML:

51.03%

Daily Std Dev

SLNO:

57.06%

TRML:

83.32%

Max Drawdown

SLNO:

-99.86%

TRML:

-94.97%

Current Drawdown

SLNO:

-93.12%

TRML:

-75.02%

Fundamentals

Market Cap

SLNO:

$2.07B

TRML:

$566.70M

EPS

SLNO:

-$2.79

TRML:

-$2.49

Total Revenue (TTM)

SLNO:

$3.45M

TRML:

$2.28M

Gross Profit (TTM)

SLNO:

$1.97M

TRML:

$1.12M

EBITDA (TTM)

SLNO:

-$136.50M

TRML:

-$71.01M

Returns By Period

In the year-to-date period, SLNO achieves a 12.25% return, which is significantly higher than TRML's -21.12% return.


SLNO

YTD

12.25%

1M

-17.30%

6M

9.79%

1Y

19.24%

5Y*

6.79%

10Y*

-9.77%

TRML

YTD

-21.12%

1M

-9.11%

6M

34.97%

1Y

-12.50%

5Y*

N/A

10Y*

N/A

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SLNO vs. TRML - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Soleno Therapeutics, Inc. (SLNO) and Tourmaline Bio Inc. (TRML). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SLNO, currently valued at 0.45, compared to the broader market-4.00-2.000.002.000.450.10
The chart of Sortino ratio for SLNO, currently valued at 1.06, compared to the broader market-4.00-2.000.002.004.001.060.74
The chart of Omega ratio for SLNO, currently valued at 1.12, compared to the broader market0.501.001.502.001.121.10
The chart of Calmar ratio for SLNO, currently valued at 0.88, compared to the broader market0.002.004.006.000.880.10
The chart of Martin ratio for SLNO, currently valued at 1.91, compared to the broader market-5.000.005.0010.0015.0020.0025.001.910.17
SLNO
TRML

The current SLNO Sharpe Ratio is 0.45, which is higher than the TRML Sharpe Ratio of 0.10. The chart below compares the historical Sharpe Ratios of SLNO and TRML, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50JulyAugustSeptemberOctoberNovemberDecember
0.45
0.10
SLNO
TRML

Dividends

SLNO vs. TRML - Dividend Comparison

Neither SLNO nor TRML has paid dividends to shareholders.


TTM2023
SLNO
Soleno Therapeutics, Inc.
0.00%0.00%
TRML
Tourmaline Bio Inc.
0.00%57.75%

Drawdowns

SLNO vs. TRML - Drawdown Comparison

The maximum SLNO drawdown since its inception was -99.86%, which is greater than TRML's maximum drawdown of -94.97%. Use the drawdown chart below to compare losses from any high point for SLNO and TRML. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-23.66%
-75.02%
SLNO
TRML

Volatility

SLNO vs. TRML - Volatility Comparison

The current volatility for Soleno Therapeutics, Inc. (SLNO) is 12.79%, while Tourmaline Bio Inc. (TRML) has a volatility of 21.02%. This indicates that SLNO experiences smaller price fluctuations and is considered to be less risky than TRML based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%JulyAugustSeptemberOctoberNovemberDecember
12.79%
21.02%
SLNO
TRML

Financials

SLNO vs. TRML - Financials Comparison

This section allows you to compare key financial metrics between Soleno Therapeutics, Inc. and Tourmaline Bio Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab